Join to view full profile
262 Danny Thomas PlMemphis, TN 38105
Phone+1 888-226-4343
Dr. Triplett is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2003 - 2006
SSM Health/Saint Louis University School of MedicineResidency, Pediatrics, 2000 - 2003- Saint Louis University School of MedicineClass of 2000
Certifications & Licensure
TN State Medical License 2004 - 2028
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies Start of enrollment: 2007 Dec 14
- Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy Start of enrollment: 2013 May 16
- Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation
Publications & Presentations
PubMed
- HLA loss-mediated immune escape of acute leukemias in pediatric patients post haploidentical transplantation.Paula Y Arnold, Subodh Selukar, Guangjin Luo, Ying Li, Rebecca Epperly
Bone Marrow Transplantation. 2025-08-01 - 23 citationsEASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients after CD19-CAR T-cell therapy.Dua'a Zandaki, Subodh Selukar, Yu Bi, Ying Li, Megan Zinsky
Blood Advances. 2025-01-28 - 4 citationsSafety and Efficacy of High-Dose Memory CD45RODonor Lymphocyte Infusion in Pediatric Recipients after Hematopoietic Stem Cell Transplantation.Mercedes Gasior Kabat, Ying Li, Victor Galán, Yasmina Mozo, Luisa Sisinni
Cytotherapy. 2024-12-01
Journal Articles
- Selective T‐Cell Depletion Targeting CD45RA Reduces Viremia and Enhances Early T‐Cell Recovery Compared with CD3‐Targeted T‐Cell DepletionBrandon M Triplett, David R Shook, Ewelina Mamcarz, Randall T Hayden, Shane J Cross, Ashok Srinivasan, Transplant Infectious Disease
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
